Please refer to JobSuchmaschine in your application
Validation and Analytical Development Manager Small Molecules
SIRE Life Sciences® is the market leader in life science recruitment. We believe the recruitment market needs to gear up in technology and continues innovation. We like technology, in a life science market driven on science, we couldn’t stay behind; we drive Recruitment Science. Investing a majority of our turnover in technology enables us to use unique Resource Technologies. By using highly advanced algorithms, we enable our team of Resource & Data Strategists© to maintain the most advanced, detailed and complete Life Sciences network in Europe. This big data enables us to work Reverse Recruitment©: we first analyze the market in-depth before we go out to the market. Because we analyze the whole market, we can compare facts and data. This enables us to do Facts & Big Data Recruitment©, making sure we, or better yet, you find the right career!
Our client is a professional Biotechnology and Pharmaceutical organization, based in Basel-Stadt Switzerland.
Our client is a major organisation in the Basel region
Development and optimization of stability indicating analytical methods for the determination of new drug products
(e.g. content, related substances, dissolution, …)
Forced degradation studies of drug products Validation of analytical methods
Determination of chemical structure of impurities
Planning, coordinating and directing GMP QC analytical tasks (e.g. release analysis, stability analysis)
Contact for 3rd parties, e.g. CMO’s
Establishing analytical profiles for INDs and NDAs
Managing a team of 1-2 technicians
Establishment of specifications for drug products
Active representation of analytics in technical project team
PhD in chemistry/PharmD
At least 3 years of experience as chemist or pharmacist
Background in Drug Products analytical chemistry, small molecules
Good Knowledge in GMP
Are you interested and do want to apply for this role, please fill out your application via the apply button below and contact Daniel Woudenberg.